important information for the patient.
used for
The active substance of Lidocaini hydrochloridum Noridem, 20 mg/ml is lidocaine hydrochloride.
Lidocaine is a local and regional anesthetic. It is used to anesthetize a specific area of the body before a surgical procedure.
This medicine can be administered to adults and children. However, when administering the medicine to a child, special precautions should be taken (see also "How to use Lidocaini hydrochloridum Noridem, 20 mg/ml"). In particular, it should be taken into account that there is limited data available on the use of the medicine in children under 2 years of age.
Additionally, the medicine can be used to control severe ventricular arrhythmias (ventricular tachycardia or tachyarrhythmia), but only if the doctor considers the patient's condition life-threatening.
This medicine can be administered to adults and children. However, when administering the medicine to a child, special precautions should be taken (see also "How to use Lidocaini hydrochloridum Noridem, 20 mg/ml"). In particular, it should be taken into account that there is limited data available on the use of the medicine in children.
mg/ml
Before administering this medicine to you, your doctor will ensure that emergency equipment is available.
The medicine is administered only under close medical supervision. The doctor will be particularly cautious if you have any of the following conditions:
Your doctor will consider that there is an increased risk of neurological side effects when this medicine is administered in the head and neck area.
Control of ventricular arrhythmias
In the treatment of heart problems, if you have severe acidosis (acidosis),
this medicine is administered with caution.
Before administering large doses of this medicine to you, your doctor will correct any low potassium levels in your blood, oxygen deficiency, and acid-base imbalance. If you receive this medicine for a long period, your doctor will monitor your fluid balance, electrolyte levels in your blood, and acid-base balance. During administration of the medicine, your doctor will monitor your heart rate, blood pressure, level of consciousness, and breathing.
Note:
If you are anesthetized, your doctor will closely monitor your condition, as side effects from the nervous system and heart may go unrecognized and occur without prior warning signs.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
This is necessary because your doctor needs to assess whether the medicines you are taking are metabolized by specific enzymes or affect their function (cytochrome P450 1A2 and 3A4). This is done to avoid interactions between Lidocaini hydrochloridum Noridem 20 mg/ml (2 % w/v) and other medicines you are taking.
In particular, you should inform your doctor if you are taking any of the following medicines:
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor or pharmacist before using this medicine. The use of the medicine during pregnancy and breastfeeding will be decided by your doctor.
Pregnancy
If you are pregnant, your doctor will administer this medicine only if necessary. The dose should be as low as possible.
Breastfeeding
Lidocaine and its metabolites pass into breast milk in small amounts. Therefore, if you are breastfeeding, your doctor will be cautious. However, in general, at usual doses, this medicine will not affect the breastfed baby. There is no need to stop breastfeeding.
The effect of lidocaine on the ability to drive and use machines depends on the type of procedure performed and the dose used. You should consult your doctor, especially if the areas of the body that were anesthetized are involved in driving or using machines. If your doctor considers it necessary, you should avoid driving and using machines.
Ampoules of 2 ml, 5 ml, and 10 ml:
The medicine contains less than 1 mmol (23 mg) of sodium per ampoule, which means the medicine is considered "sodium-free".
Ampoules of 20 ml:
The medicine contains 38.1-41.0 mg of sodium (the main component of table salt) in each 20 ml ampoule.
This corresponds to 1.90-2.05% of the maximum recommended daily intake of sodium in the diet for adults.
This medicine is administered by a doctor.
This medicine is administered by injection into a vein, under the skin, into a muscle, bone, spine, or nerve.
The dose is determined by your doctor. It depends on your individual condition.
Local and regional anesthesia
Adults
The usual maximum dose is 4.5 mg/kg body weight (or 300 mg). If the medicine is used together with a vasoconstrictor, the maximum dose can be increased to 7 mg/kg body weight (or 500 mg).
Children and adolescents
In children and adolescents, the dose is determined individually, based on age, body weight, and the type of procedure. In children, the maximum dose is 5 mg/kg body weight. If the medicine is used together with a vasoconstrictor, the maximum dose can be increased to 7 mg/kg body weight.
In children, a lower concentration of the medicine (0.5%) should be used for anesthesia. For a special technique called complete motor block, a higher concentration (1% w/v) may be necessary.
In children under 2 years of age, this medicine should be used with caution.
Control of ventricular arrhythmias
The dose should be adjusted to individual needs and expected therapeutic effect.
This is especially important in patients with heart, liver, or kidney problems, as well as in pregnant women.
In some patient groups, a reduced dose of lidocaine is used. These include:
The occurrence of overdose symptoms in you depends on the level of lidocaine in your blood. The more lidocaine circulating in your blood and the faster it is administered, the more likely and severe the overdose symptoms will be.
Mild overdose mainly affects the central nervous system. If side effects occur, in most cases, they will resolve on their own after the administration of lidocaine is stopped.
The initial symptoms of lidocaine poisoning are:
In case of any further questions related to the use of this product, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The frequency and severity of side effects of this medicine depend on the dose administered, the technique used, and your individual reaction to lidocaine.
After administration of this medicine, local toxicity symptoms may occur. Systemic side effects may occur when the lidocaine concentration in your blood exceeds 5-10 mg/l. You may experience symptoms from the central nervous system, cardiovascular system, and heart (see also "Using a higher dose of Lidocaini hydrochloridum Noridem, 20 mg/ml than recommended").
The following side effects can be serious. If you experience any of the following side effects, you should immediately inform your doctor. Immediate action may be necessary:
rarely (may occur in less than 1 in 1000 patients):
rarely (may occur in less than 1 in 1000 patients):
Control of ventricular arrhythmias
The following side effects can be serious. If you experience any of the following side effects, you should immediately inform your doctor. Immediate action may be necessary:
rarely (may occur in less than 1 in 1000 patients):
very rare (may occur in less than 1 in 10,000 patients):
very common (may occur in more than 1 in 10 patients):
Elderly patients
Elderly patients may be more prone to certain side effects mentioned above.
Children
The frequency, type, and severity of side effects in children are likely to be the same as in adults.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or nurse. Side effects can also be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181C
02-222 Warsaw,
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl .
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the ampoule and carton after "EXP". The expiry date refers to the last day of the month stated.
The solution for injection should be administered immediately after opening the packaging.
The packaging is for single use only. After opening, the packaging should be discarded along with any unused contents.
The solution for injection is suitable for use only if it is clear, colorless, and practically free of particles, and the packaging and closure are not damaged.
Chemical and physical stability after dilution has been demonstrated for up to 24 hours at both 25°C and 2-8°C when diluted with sodium chloride 9 mg/ml (0.9%) solution or glucose 50 mg/ml (5%) solution. From a microbiological point of view, the product should be used immediately. If the ready-to-use solution for injection is not used immediately, the in-use storage time and conditions are the responsibility of the user and would not normally be longer than 24 hours at 2-8°C, unless dilution has taken place in controlled and validated aseptic conditions.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Lidocaini hydrochloridum Noridem, 20 mg/ml, solution for injection is a clear and colorless solution.
PP ampoules of 2 ml, 5 ml, 10 ml, and 20 ml in a cardboard box. Each packaging contains 5, 10, 20, 50, or 100 ampoules.
Not all pack sizes may be marketed.
Noridem Enterprises Limited
Evagorou & Makariou
Mitsi Building 3, Office 115
1065 Nicosia
Cyprus
DEMO S.A.
PHARMACEUTICAL INDUSTRY
21st km National Road Athens-Lamia
14568 Krioneri
Attica, Greece
Phone: +30 210 8161802, Fax: +30 2108161587
Use of lidocaine for local and regional anesthesia during pregnancy
The use of lidocaine for epidural, pudendal nerve block, or cervical anesthesia may have toxic effects on the fetus and newborn (e.g., bradycardia, hypotension, or respiratory depression). Accidental subcutaneous injection of lidocaine into the fetus during cervical or pudendal nerve block may cause apnea, hypoxia, and seizures, and thus pose a risk to the newborn's life.
In general, during pregnancy, lidocaine should be used at a concentration of 10 mg/ml.
More information, especially on dosing and administration, can be found in the summary of product characteristics.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.